Daily Management Review

DMR

Don't Miss

Emerging Opportunities Amid U.S. Tariffs: Brazil, Egypt, and Singapore Poised to Benefit 04/08/2025

Airbus delivers 136 airplanes to customers in Q1, ahead of Boeing 04/10/2025

JPMorgan raises global recession forecast to 60% from 40% 04/07/2025

Economics

Business & Finance

Management

World & Politics

Science & Technology

Art & Art Market

Science & Technology

US Moderna estimates anti-COVID 19 vaccinations at $ 50-60

Biotech company Moderna wants to sell a dose of the coronavirus vaccine for between $ 25 and $ 30, sources close to the company's talks with potential buyers told the Financial Times (FT). A course of vaccinations will cost $ 50-60. This price can be set for the United States and other high-income...

Hacker attack named as reason for Garmin services failure

Services of the well-known manufacturer of smart watches and electronic devices for sports Garmin have not been working since July 23, writes the BBC. ZDNet portal reports that the failure was caused by a hacker attack. According to them, the attackers have encrypted the system data and are...

New Report In UK Finds Risks Of Death From Covid-19 Increased By Obesity

A latest report by the Public Health England (PHE) has claimed that there is an increased risk of illness or even death from the infection of the novel coronavirus caused disease Covid-19 for people who are overweight. "The current evidence is clear that being overweight or obese puts you...

UK to transfer majority of taxpayers to electronic filing by 2023

The UK plans to almost completely transfer taxpayers to electronic filing of tax returns from April 2023, according to a statement from the country's Treasury. The changes are being introduced as part of a phased program to digitize the tax system, which began in 2019. Currently, companies with a...

Positive Results Emerge From The Oxford Coronavirus Vaccine Trials

The much awaited results of the first phase of human testing of a novel coronavirus vaccine candidate developed by the University of Oxford are out and they show that the dose is apparently safe and is able to train the human immune system. This trial comprised of a total of 1,077 people...

EU In Negotiations With Moderna, Biontech, Curevac For Cvodi-19 Vaccinees; Reuters

Negotiations are currently underway by the European Union to secure vaccines against Covid-19 with pharma companies working on vaccines including Moderna, Sanofi and Johnson & Johnson and biotech firms BioNtech and CureVac, claimed a report published by the news agency Reuter citing sources in...

Twitter’s Own ‘Admin’ Tool Used By Hacker To Spread Cryptocurrency Scam

Access to an “admin” tool on Twitter’s network was allegedly gained by hacker who has been reported to have been behind the spate of Twitter account hacks on Wednesday. According to reports quoting sources with knowledge of the matter, this access allowed the hacker to hijack high-profile Twitter...

World's First Human Trial For Covid-19 Vaccine Completed By Russia

In a major development in the fight to find a vaccine for Covid -19, clinical trials of a vaccine for the respiratory disease caused by the novel coronaviruss on humans was completed by Russian scientists. This made Russia the first nation to complete such clinical trials for a Covid-19 vaccine....

Indian Drug Regulator Approves India’s Biocon's Itolizumab For Treatment Of Covid-19

In a landmark move in the fight against Covid-19, Indian drug regulator the Drug Controller General of India approved the use of Itolizumab on Covid-19 patients, the disease caused by the novel coroanvirus. The drug has been developed by the Indian biotech company Biocon. This drug is...

COVID-19 Transmits Through Air Claim Scientists Urging WHO To Revise Guidelines

Scientists have claimed that they have enough evidence to show that smaller airborne particles traveling across the room can infect people inhaling them. If the reports of the New York Times are to be believed, on Saturday, July 4, 2020, it reported that hundreds of scientists are of the opinion...